Trade Mark Journal No.2026/018 1 May 2026
WO0000001913573 (1,5,35,42)
Office of origin: Switzerland
Date of International Registration:26 November 2025
Date of designation in the UK:
26 November 2025
International priority date claimed: 16 June 2025
(Switzerland)
(834415)
- Class 1
- Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science; bioactive reagents and compounds; peptides, peptide derivatives, proteins, glycans, nucleotides, lipids, antibodies, antibody-active principle conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; chemical, biochemical, biological, biotechnological and molecular genetic preparations for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides, peptide derivatives or proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals.
- Class 5
- Pharmaceutical products, medical preparations; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely peptides, peptide derivatives, proteins, antibodies, active antibody conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; pharmaceutical products and substances for the treatment of diseases and preparations for medical treatments.
- Class 35
- Providing information with respect to business contacts for research projects.
- Class 42
- Scientific and technological services as well as research work and design services relating thereto, namely, services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; services of a biochemical or pharmaceutical laboratory; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results.
Araris Biotech AG
Representative: Vossius & Partner Patentawälte Rechtsanwälte mbB, Hirschgässlein 11, CH-4051 Basel, SWITZERLAND